Comet Resources Ltd(CRL.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

CRL.AU Comet Resources Ltd

Closed 11-15 16:00:00 AEDT

0.20

+0.00

0.00%

High0.20	Low0.20	Vol0.00
Open0.20	D1 Closing0.20	Amplitude0.00%
Mkt Cap13.83M	Tradable Cap5.24M	Total Shares69.16M
T/O0.00	T/O Rate0.00%	Tradable Shares26.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CRL.AU","market":"AU","secType":"STK","nameCN":"Comet Resources Ltd","latestPrice":0.2,"timestamp":1731646800000,"preClose":0.2,"halted":9,"volume":0,"delay":0,"nameEN":"Comet Resources Ltd","floatShares":26192756,"shares":69159244,"eps":-0.029502,"marketStatus":"Closed","change":0,"latestTime":"11-15 16:00:00 AEDT","open":0.2,"high":0.2,"low":0.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.029502,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1731884400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.2,"openAndCloseTimeList":[[1731625200000,1731646800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/CRL.AU/tweets","defaultTab":"tweets","newsList":[{"id":"2476237627","title":"FibroBiologics, Charles River Laboratories Team Up to Make Fibroblast-Based Treatments for Chronic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2476237627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476237627?lang=en_us&edition=fundamental","pubTime":"2024-10-18 21:25","pubTimestamp":1729257931,"startTime":"0","endTime":"0","summary":"FibroBiologics (FBLG) and Charles River Laboratories (CRL) said Friday they have set up a master services agreement to make FibroBiologics' fibroblast-based CYWC628 for a diabetic foot ulcer trial exp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","BK4120","BK4588","CRL.AU","BK4585","FBLG","CRL","BK4530","BK4139","LU0390134368.USD","BK7095","TISI"],"gpt_icon":0},{"id":"2472524409","title":"Charles River Laboratories International, Lundbeck Enter Deal for Logica Platform in Brain Disease Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2472524409","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472524409?lang=en_us&edition=fundamental","pubTime":"2024-10-02 22:39","pubTimestamp":1727879989,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International  said Wednesday that it agreed to a deal with H. Lundbeck to use Logica artificial intelligence-powered drug discovery platform for brain disease research.Financial terms of the agreement were not disclosed.Charles River shares were down 1.4% in recent trading.Price: 191.33, Change: -2.75, Percent Change: -1.42","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRL.AU","BK4588","LU0390134368.USD","BK4585","BK4530","BK7095","BK4121","CRL"],"gpt_icon":0},{"id":"2468352326","title":"Charles River Laboratories, CEBINA Partner to Accelerate Neurodegenerative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2468352326","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468352326?lang=en_us&edition=fundamental","pubTime":"2024-09-17 21:32","pubTimestamp":1726579942,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International  said Tuesday it has entered a partnership with Central European Biotech Incubator and Accelerator, or CEBINA, to support CEBINA's DanubeNeuro program, aimed at accelerating innovative academic research in neurodegenerative diseases.Financial details of the partnership weren't disclosed.The partnership combines Charles River's central nervous system drug development expertise with CEBINA's focus on advancing novel drugs, diagnostics, and biomarkers for conditions like Alzheimer's and Parkinson's, Charles River Laboratories said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4530","CRL.AU","BK7095","BK4585","BK4588","LU0390134368.USD","AAQC","BK4121","CRL"],"gpt_icon":0},{"id":"2464023673","title":"Charles River Laboratories, Insightec Collaborate on Focused Ultrasound in Neuroscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2464023673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464023673?lang=en_us&edition=fundamental","pubTime":"2024-09-04 23:15","pubTimestamp":1725462934,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International (CRL) and Insightec said Wednesday they're launching a five-year collaboration.Under the partnership, Charles River's customers will get access to a platform f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRL.AU","BK4121","BK4585","BK4588","LU0390134368.USD","BK7095","CRL","BK4530"],"gpt_icon":0},{"id":"2458532325","title":"Morgan Stanley Cuts Price Target on Charles River Laboratories International to $215 From $235","url":"https://stock-news.laohu8.com/highlight/detail?id=2458532325","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458532325?lang=en_us&edition=fundamental","pubTime":"2024-08-09 02:35","pubTimestamp":1723142107,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["LU0106831901.USD","BK4121","BK4505","BK4534","BK4581","CRL","LU0098860793.USD","BK4504","BK4530","LU1668664300.SGD","BK7095","IE00BKVL7J92.USD","LU1074936037.SGD","LU0267386448.USD","BK4006","BK4552","CRL.AU","BK4531","LU1989772840.SGD","LU1363072403.SGD","LU0320765646.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","BK4561","BK4585","BK4108","BK4526","IQ","LU1162221912.USD","LU0390134368.USD","LU1989772923.USD","LU0314104364.USD","BK4127","MT","BK4588"],"gpt_icon":0},{"id":"2457343217","title":"Stephens Adjusts Price Target on Charles River Laboratories International to $240 From $250","url":"https://stock-news.laohu8.com/highlight/detail?id=2457343217","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457343217?lang=en_us&edition=fundamental","pubTime":"2024-08-08 23:05","pubTimestamp":1723129533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["CRL","MT","BK4108","BK4530","BK4552","BK4561","CRL.AU","LU0390134368.USD","BK4006","BK4526","BK4585","BK4531","BK4121","BK7095","BK4505","IQ","BK4588"],"gpt_icon":0},{"id":"2457471393","title":"Baird Downgrades Charles River Laboratories International to Neutral From Outperform, Adjusts PT to $191 From $239","url":"https://stock-news.laohu8.com/highlight/detail?id=2457471393","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457471393?lang=en_us&edition=fundamental","pubTime":"2024-08-08 18:45","pubTimestamp":1723113953,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4166","BK4006","BK4505","MT","PT","BK4108","BK4530","BK4585","CRL.AU","LU0390134368.USD","BK4121","BK4552","BK7095","CRL","BK4531","BK4561","BK4588","IQ","BK4526"],"gpt_icon":0},{"id":"2457932623","title":"JPMorgan Downgrades Charles River Laboratories International to Neutral From Overweight, Adjusts PT to $205 From $270","url":"https://stock-news.laohu8.com/highlight/detail?id=2457932623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457932623?lang=en_us&edition=fundamental","pubTime":"2024-08-08 18:45","pubTimestamp":1723113938,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["LU1032466523.USD","IQ","MT","BK4006","LU0070302665.USD","BK4526","LU1894683264.USD","LU1670627923.USD","IE00B1BXHZ80.USD","LU1119994496.HKD","IE000M9KFDE8.USD","BK4566","IE00B3S45H60.SGD","BK4531","PT","LU1084165304.USD","LU0882574139.USD","IE00BJTD4N35.SGD","LU1261432733.SGD","LU0971096721.USD","LU0320765489.SGD","LU1267930490.SGD","LU0211326755.USD","LU0211331839.USD","LU0211327993.USD","CRL","IE00BLSP4239.USD","LU1064131342.USD","IE00B1XK9C88.USD","IE00BKVL7J92.USD","LU1894683348.USD","LU0106831901.USD","LU0256863811.USD","LU1244550577.SGD","BK4108","BK4552","BK4530","LU1162221912.USD","LU1244550494.USD","LU0320765646.SGD","BK4581","CRL.AU","LU1496350502.SGD","BK4505","LU0976567544.SGD","LU0267386448.USD","IE00BBT3K403.USD","BK7095","LU","LU0170899867.USD"],"gpt_icon":0},{"id":"2457988593","title":"Baird Downgrades Charles River Laboratories International to Neutral From Outperform, Adjusts PT to $191 From $239","url":"https://stock-news.laohu8.com/highlight/detail?id=2457988593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457988593?lang=en_us&edition=fundamental","pubTime":"2024-08-08 18:24","pubTimestamp":1723112659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4166","BK7095","BK4588","LU0390134368.USD","BK4531","BK4526","BK4530","BK4505","BK4121","BK4561","CRL","CRL.AU","PT","MT","BK4585","BK4108","BK4552","BK4006","IQ"],"gpt_icon":0},{"id":"2457981740","title":"Charles River Laboratories' Q2 Non-GAAP Earnings Rise, Revenue Falls; 2024 Outlook Slashed","url":"https://stock-news.laohu8.com/highlight/detail?id=2457981740","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457981740?lang=en_us&edition=fundamental","pubTime":"2024-08-07 19:56","pubTimestamp":1723031785,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["CRL","BK4505","BK4108","BK4530","BK4552","LU0390134368.USD","CRL.AU","BK4585","BK4531","BK4121","BK7095","BK4526","IQ","BK4588"],"gpt_icon":0},{"id":"2454880274","title":"Charles River Laboratories Invests in Autobahn Labs Under Collaborative Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2454880274","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454880274?lang=en_us&edition=fundamental","pubTime":"2024-07-25 00:15","pubTimestamp":1721837752,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International  has made an investment in Autobahn Labs, joining a fundraising round led by Autobahn's founding investor, Samsara BioCapital, the companies said Wednesday.They said Charles River will be the preferred research partner for Autobahn's pipeline of early-stage, preclinical therapeutics' programs as part of their partnership. The agreement will also grant Autobahn preferred access to Charles River's drug discovery and development capabilities.The investment and collaboration will enable Autobahn to expand its partnerships with academic institutions, advance preclinical programs, and identify new opportunities for therapeutics development, the companies said. Justin Bryans, chief scientific officer, discovery for Charles River, has joined Autobahn's board.Charles River shares were up about 2% in recent trading.Price: 224.95, Change: +4.67, Percent Change: +2.12","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","LU0390134368.USD","CRL.AU","BK4588","BK4121","CRL","BK4585","BK4530"],"gpt_icon":0},{"id":"2454800398","title":"Charles River Laboratories Invests in Autobahn Labs Under Collaborative Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2454800398","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454800398?lang=en_us&edition=fundamental","pubTime":"2024-07-25 00:15","pubTimestamp":1721837752,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4121","BK4530","BK4588","BK4585","BK7095","CRL.AU","CRL","LU0390134368.USD"],"gpt_icon":0},{"id":"2450289060","title":"Baird Adjusts Price Target on Charles River Laboratories International to $239 From $271","url":"https://stock-news.laohu8.com/highlight/detail?id=2450289060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450289060?lang=en_us&edition=fundamental","pubTime":"2024-07-10 21:26","pubTimestamp":1720617990,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4588","BK4530","BK7095","IQ","BK4561","BK4006","BK4108","BK4531","BK4121","BK4526","CRL.AU","CRL","BK4552","LU0390134368.USD","BK4505","BK4585","MT"],"gpt_icon":0},{"id":"2446177501","title":"Argus Downgrades Charles River Laboratories International to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2446177501","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446177501?lang=en_us&edition=fundamental","pubTime":"2024-06-28 20:21","pubTimestamp":1719577290,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4505","BK4526","BK4561","LU0390134368.USD","BK4531","BK4585","BK4588","BK7095","CRL","BK4552","IQ","BK4121","BK4108","MT","BK4006","BK4530","CRL.AU"],"gpt_icon":0},{"id":"2446086842","title":"Charles River Laboratories, Gates Institute Collaborate on Lentiviral Vector Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2446086842","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446086842?lang=en_us&edition=fundamental","pubTime":"2024-06-25 22:27","pubTimestamp":1719325663,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4585","BK4121","BK4544","CRL.AU","BK4588","ARKG","BK4530","VGR","LU0390134368.USD","BK7095","BK4139","CDMO","VAQC","BK4075","CRL"],"gpt_icon":0},{"id":"2444191487","title":"Charles River Laboratories, Captain T Cell Enter Manufacturing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2444191487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444191487?lang=en_us&edition=fundamental","pubTime":"2024-06-17 23:58","pubTimestamp":1718639896,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4139","DNA","BK4530","BK4121","BK4588","CRL","LU0390134368.USD","BK4109","BK4585","BK7095","CRL.AU"],"gpt_icon":0},{"id":"2444188191","title":"Charles River Laboratories, Captain T Cell Enter Manufacturing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2444188191","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444188191?lang=en_us&edition=fundamental","pubTime":"2024-06-17 23:58","pubTimestamp":1718639896,"startTime":"0","endTime":"0","summary":"Charles River Laboratories  and Captain T Cell said Monday that they have entered into a plasmid DNA and retrovirus vector production program deal.Captain T Cell will use plasmid and viral vector contract development and manufacturing organization services under Charles River's cell and gene therapy accelerator program, the companies said.This will support Captain T Cell's preparation to manufacture a T cell receptor T cell therapy for solid tumor patients for a phase 1 trial, the companies added.Price: 208.55, Change: -0.92, Percent Change: -0.44","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","LU0390134368.USD","BK4585","BK4530","CRL","BK4588","CRL.AU","BK4121"],"gpt_icon":0},{"id":"2443110503","title":"Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270","url":"https://stock-news.laohu8.com/highlight/detail?id=2443110503","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443110503?lang=en_us&edition=fundamental","pubTime":"2024-06-13 18:19","pubTimestamp":1718273988,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4588","BK4561","CRL.AU","BK4121","CRL","IQ","BK4530","BK4006","MT","LU0390134368.USD","BK4585","BK7095"],"gpt_icon":0},{"id":"2441030876","title":"Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2441030876","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441030876?lang=en_us&edition=fundamental","pubTime":"2024-06-07 17:32","pubTimestamp":1717752735,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4108","BK4530","LU0390134368.USD","BK4207","BK4121","MFG","CRL.AU","BK4585","BK4531","BK4552","BK4505","BK4006","IQ","BK4561","MT","BK7095","BK4588","CRL","BK4526"],"gpt_icon":0},{"id":"2441745396","title":"Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts","url":"https://stock-news.laohu8.com/highlight/detail?id=2441745396","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441745396?lang=en_us&edition=fundamental","pubTime":"2024-06-06 22:39","pubTimestamp":1717684781,"startTime":"0","endTime":"0","summary":"Charles River Laboratories  said Thursday it has opened a new Charles River Accelerator and Development Lab facility in Somerville, Massachusetts, to expand access to contract vivarium space.The new facility is expected to meet growing demand for more flexible vivarium and bench space, along with on-demand in vivo study support services, in Massachusetts, the company said.Shares of Charles River Laboratories were up about 1.7% in recent trading.Price: 219.70, Change: +3.58, Percent Change: +1.66","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4121","CRL.AU","BK4588","BK4530","BK7095","LU0390134368.USD","CRL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cometres.com.au","compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0252},{"period":"3month","weight":-0.022},{"period":"6month","weight":-0.0006},{"period":"1year","weight":0.1369},{"period":"ytd","weight":0.1205}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Comet Resources Limited operates as a mineral exploration company in Australia. It owns a 100% interest in the Springdale Graphite project located in Western Australia; and a 25% interest in the Bell's find project. The company was founded in 1994 and is based in Subiaco, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.518519,"avgChangeRate":0.054508},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.009668},{"month":3,"riseRate":0.392857,"avgChangeRate":-0.000026},{"month":4,"riseRate":0.392857,"avgChangeRate":0.017926},{"month":5,"riseRate":0.241379,"avgChangeRate":-0.078754},{"month":6,"riseRate":0.535714,"avgChangeRate":0.055474},{"month":7,"riseRate":0.37931,"avgChangeRate":-0.003218},{"month":8,"riseRate":0.517241,"avgChangeRate":0.048172},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.026536},{"month":10,"riseRate":0.5,"avgChangeRate":0.021228},{"month":11,"riseRate":0.241379,"avgChangeRate":-0.014353},{"month":12,"riseRate":0.407407,"avgChangeRate":0.112777}],"exchange":"ASX","name":"Comet Resources Ltd","nameEN":"Comet Resources Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Comet Resources Ltd(CRL.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Comet Resources Ltd(CRL.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Comet Resources Ltd,CRL.AU,Comet Resources Ltd股票,Comet Resources Ltd股票老虎,Comet Resources Ltd股票老虎国际,Comet Resources Ltd行情,Comet Resources Ltd股票行情,Comet Resources Ltd股价,Comet Resources Ltd股市,Comet Resources Ltd股票价格,Comet Resources Ltd股票交易,Comet Resources Ltd股票购买,Comet Resources Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Comet Resources Ltd(CRL.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Comet Resources Ltd(CRL.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction